Transcriptional regulation in disease: opportunities, challenges, and the future

from The Studio at Kendall Square · host BiotechTV

Cigall Kadoch, associate professor and HHMI Investigator, Dana-Farber Cancer Institute and Harvard Medical School, and scientific founder of Foghorn Therapeutics (NASDAQ: FHTX), interviews Rick Young, professor of biology at MIT and member of the Whitehead Institute about the latest research and knowledge of how transcriptional regulation can be harnessed and targeted in drug development.

Episode metadata supplied by the publisher feed · Published Oct 24, 2024

Embed this episode

Attribution link and audio player

Ready to play

Transcriptional regulation in disease: opportunities, challenges, and the future

0:00 19:53

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Studio at Kendall Square?

This episode is 19 minutes long.

When was this The Studio at Kendall Square episode published?

This episode was published on October 24, 2024.

Can I download this The Studio at Kendall Square episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!